glp 1 agonist diabetes GLP1 Receptor Agonists—Effects beyond Obesity and The activity of GLP-1 and
Description
R Core Team
The effect of liraglutide on renal function: a randomized clinical trial
Public awareness of GLP-1 medications has also surged in recent years, with about 91% of respondents in 2026 reporting they knew the drugs could treat weight lossup from 80% in 2024
This includes trials of drug combinations such as Novo Nordisks CagriSema that combines semaglutide with investigational drug cagrilintide to improve efficacy
Treatment with GLP-1 receptor agonists partially reversed these changes by lowering BMP4 expression, suppressing tumor growth, and inducing apoptosis (Ma et al., 2023)
